Form 4: Clorox Director Shattock Reports Stock Unit Transactions

Matthew J. Shattock, a Director at The Clorox Company, reported transactions involving deferred stock units acquired through dividend reinvestment and in lieu of director's fees.

Summary

• Matthew J. Shattock, a Director of The Clorox Company (CLX), has filed a Form 4 detailing transactions related to deferred stock units.
• On May 8, 2026, Shattock acquired 270.7961 deferred stock units through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
• On June 30, 2026, Shattock acquired an additional 550.0838 deferred stock units in lieu of quarterly director's fees.
• These deferred stock units are convertible into Clorox common stock on a 1-for-1 basis.
• The units are set to be settled 100% in Clorox stock upon Shattock's retirement or termination of service as a Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine stock unit acquisitions by a director rather than significant strategic or financial events.

Positives

• Director Shattock's continued participation in the deferred compensation plan indicates ongoing commitment and alignment with shareholder interests.
• The acquisition of stock units through dividend reinvestment and in lieu of fees demonstrates a mechanism for directors to accumulate equity in the company.

Risks

• The value of the deferred stock units is subject to the future performance and stock price of The Clorox Company.
• Potential for conflicts of interest if compensation structures are not perceived as equitable by all stakeholders.

Future Outlook

The deferred stock units are expected to be settled in Clorox stock upon the reporting person's retirement or termination of service as a Director.

Industry Context

StockSavvy.ai notes that the use of deferred stock units and dividend reinvestment plans for directors is a common practice in the consumer staples industry to align executive and director compensation with long-term shareholder value.

Corporate Governance

Related Party Transactions

• The transactions involve a director of the company acquiring equity, which is a standard related-party transaction within the scope of executive and director compensation plans.

Stakeholder Impact

• Shareholders: The transactions reflect a standard method of director compensation, aligning director interests with those of shareholders through equity accumulation.
• Employees: Indirect impact through the company's compensation structure for its board members.
• Management: The filing is a routine disclosure related to board compensation practices.

Next Steps

• Settlement of deferred stock units in Clorox stock upon reporting person's retirement or termination of service.

Key Dates

Keywords

Form 4, SEC Filing, Clorox Company, CLX, Matthew J. Shattock, Director, Deferred Stock Units, Stock Compensation, Dividend Reinvestment, Independent Directors' Deferred Compensation Plan, Beneficial Ownership